Who are MSD?
After a merger with Schering-Plough in 2009, MSD is now one of the world’s largest healthcare companies, focusing on animal care, vaccines and pharmaceutical products.
The company’s reported revenue for 2025 was $65.0 billion.
Headquartered in Kenilworth, New Jersey, MSD now employs approximately 75,000 people worldwide.
MSD in Singapore
MSD’s presence in Singapore was established with the opening of a marketing and sales office in October 1993.
Today, the company operates 5 sites across Singapore, employing approximately 1,800 people in the country.
These sites include their Asia Pacific Regional Headquarters, pharmaceutical manufacturing, an animal health site and a research centre.
In 1997, the pharmaceutical manufacturing site was established. It has gone on to be a critical part of MSD’s global supply network. The company directly employs 1,150 people at the site, as well as “300 indirect service providers”.
The MSD Animal Health operation began in 2000, in the Lim Chu Kang Agri-Bio Park. The research here is focused on aquatic animal health and researchers work in collaboration with local universities and research institutes. MSD Animal Health is also an invited member of the Asia Regional Advisory Group (AG) on Aquatic Animal Health – a group that advises Asian governments of the management of aquatic animal health.
The Asia Pacific Regional Headquarters opened in Singapore in 2007. The President and CEO said that this was “a bold testimony to our long-term confidence in and commitment to Singapore”.
In 2009, MSD expanded their Singapore footprint into R&D when they opened their Translational Medicine Research Centre (TMRC) at the Biopolis Research Park. The work carried out here helps to inform decisions on the early drug discovery pipeline.
Most recently, in 2015, MSD established a Global IT Hub in Singapore. The work of this site is focused on progressing IT across healthcare. As a result of this site, the manufacturing-floor of the pharmaceutical site was able to move from paper-based to digital data collection and storage.
In total, MSD has invested over USD$2 billion in manufacturing since 1997, and over USD$240 million in research since 2009.